Table 3 Odds ratio of NAFLD incidence in normal uric acid group and hyperuricemia group

Male gender

11,025 (38.6%)

6947 (65.4%)

< 0.001

5706 (72.4%)

7640 (91.1%)

< 0.001

Age

46.0 ±10.6

50.0 ±9.49

< 0.001

46.2 ±11.2

47.4 ±9.98

< 0.001

BMI

22.7 ±2.81

25.8 ±2.97

< 0.001

23.6 ±2.82

26.4 ±3.12

< 0.001

SBP

118 ±16.2

128 ±15.6

< 0.001

122 ±15.8

129 ±14.7

< 0.001

DBP

70.2 ±10.7

76.8 ±10.8

< 0.001

73.2 ±11.0

79.0 ±10.8

< 0.001

WC

78.5 ±8.72

90.2 ±8.30

< 0.001

83.3 ±8.78

93.3 ±7.80

< 0.001

FBG

5.11 ±0.896

5.85 ±1.72

< 0.001

5.17 ±0.841

5.62 ±1.17

< 0.001

HbA1c

5.29 ±0.588

5.75 ±1.02

< 0.001

5.31 ±0.556

5.57 ±0.775

< 0.001

TG

1.28 ±0.898

2.21 ±1.74

< 0.001

1.69 ±1.37

2.72 ±2.12

< 0.001

TC

4.70 ±0.903

4.98 ±0.997

< 0.001

4.79 ±0.929

5.06 ±0.994

< 0.001

Hdl-c

1.31 ±0.313

1.09 ±0.250

< 0.001

1.20 ±0.300

1.03 ±0.227

< 0.001

Ldl-c

2.66 ±0.727

2.85 ±0.804

< 0.001

2.72 ±0.754

2.83 ±0.811

< 0.001

ALT

19.4 ±20.6

32.1 ±26.8

< 0.001

23.3 ±17.9

39.2 ±27.2

< 0.001

AST

19.8 ±11.3

23.6 ±13.5

< 0.001

21.3 ±10.2

26.1 ±13.6

< 0.001

TSH

1.89 ±1.58

1.87 ±1.70

0.309

1.82 ±1.94

1.81 ±1.34

0.748

FT3

2.58 ±0.892

2.68 ±0.830

< 0.001

2.62 ±0.905

2.67 ±0.849

< 0.001

FT4

2.17 ±2.00

2.06 ±1.89

< 0.001

2.18 ±2.00

2.14 ±1.95

0.173